Novartis AG

NVS Healthcare Drug Manufacturers General

Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 17.4%, free cash flow fell 15.5% and total debt rose 52.9%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three, operating cash flow growth for three.

150.62 0.24 +0.16%
Market cap
$275.3B
P/E
22.6×
Fwd P/E
20.6×
Dividend yield
3.15%
F-score
8/9
Altman Z
4.13
Beneish M
−2.49
Dividend safety
66/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
40.05 103.59 14.16 18.53 26.60 8.16 28.91 14.05 16.47 19.15
Piotroski F-Score
5 8 7 7 5 8 6 5 6 8
P/S ratio
0.00 0.00 3.87 4.46 4.31 3.71 4.63 4.50 3.80 4.72
Altman Z-Score
3.10 3.20 2.90 3.40 3.05 3.38 3.42 3.85 3.61 4.13
Altman Z″-Score (non-manufacturers)
3.84 3.79 3.63 3.02 2.62 4.13 3.62 3.34 3.20 3.35
P/FCF ratio
0.00 0.00 14.21 16.44 18.64 14.99 16.32 15.10 14.06 17.34
Beneish M-Score
(2.65) (2.68) (2.53) (2.86) (2.71) (2.20) (2.79) (2.87) (2.72) (2.49)
P/Operating CF
(21.61) (26.12) 47.35 61.28 53.69 50.51 48.92 82.36 46.83 118.08
Dividend Safety Score
— — — — — — — — — 66
P/B ratio
0.00 0.00 2.27 3.91 3.79 2.89 3.38 4.49 4.45 5.74
EV/Sales
(1.25) (1.40) 4.22 4.78 4.80 3.73 4.79 4.71 4.11 5.10
EV/EBITDA
0.00 0.00 19.02 18.77 18.01 16.86 13.97 16.53 12.11 12.62
EV/FCF
(6.51) (6.62) 15.50 17.64 20.77 15.06 16.91 15.83 15.21 18.76
Current Ratio
1.12 1.21 1.20 1.04 0.90 1.51 1.29 1.16 1.04 1.12
Net Debt/EBITDA
1.12 1.30 1.19 1.07 1.50 0.07 0.49 0.56 0.78 0.96
Debt/Equity
0.32 0.38 0.41 0.49 0.64 0.43 0.44 0.53 0.67 0.72
ROE
8.83% 10.33% 16.49% 17.48% 14.39% 38.59% 10.93% 27.97% 26.28% 30.84%
ROA
5.13% 5.85% 9.05% 8.89% 6.56% 18.51% 5.58% 13.66% 11.81% 13.12%
ROIC
5.68% 5.78% 5.54% 7.94% 7.82% 10.64% 7.45% 10.72% 15.08% 16.10%
Return on Tangible Assets
36.55% 36.22% 58.24% 88.15% 90.93% 88.79% 36.57% 109.15% 114.05% 100.14%
Average Days of Receivables
61.71 64.08 71.06 64.15 61.86 57.18 69.99 58.93 53.32 58.88
Earnings Yield
2.50% 0.97% 7.06% 5.40% 3.76% 12.26% 3.46% 7.12% 6.07% 5.22%
Free Cash Flow Yield
(12.19%) (11.87%) 7.04% 6.08% 5.36% 6.67% 6.13% 6.62% 7.11% 5.77%
Free Cash Flow per Share
3.98 4.50 5.41 5.76 5.07 5.84 5.65 6.69 6.92 7.95
Book value per Share
31.49 31.64 33.93 24.25 24.89 30.24 27.25 22.51 21.87 24.01
Free Cash Flow
9,455.00 10,566.00 12,549.00 13,198.00 11,533.00 13,088.00 12,325.00 13,897.00 13,971.00 15,421.00
EV/EBIT
0.00 0.00 22.80 25.63 23.59 16.86 26.22 22.52 14.61 16.40
Other line items

Show all line items

Columns are period end dates